RecruitingNCT06177743
IRIS-Coroflex NEO Cohort
Evaluation of Effectiveness and Safety of Coroflex ISAR NEO Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study
Sponsor
Seung-Jung Park
Enrollment
1,000 participants
Start Date
Jan 9, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
The objective of this study is to evaluate the effectiveness and safety of Coroflex ISAR NEO stents in comparison to other drug-eluting stents (DES) in real-world practice.
Eligibility
Min Age: 19 Years
Inclusion Criteria3
- Patients ≥ 19 years old
- Patients receiving Coroflex ISAR NEO stents.
- The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.
Exclusion Criteria3
- Patients with a mixture of other DESs
- Terminal illness with life expectancy <1 year.
- Patients with cardiogenic shock
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICECoroflex ISAR NEO stent
Percutaneous coronary intervention with Coroflex ISAR NEO stent
Locations(11)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06177743
Related Trials
Evaluation of Effectiveness and Safety of Ultimaster™ Tansei™ Stent and/or Ultimaster Nagomi™ Stent in Routine Clinical Practice
NCT0444353011 locations
Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy
NCT0441658145 locations
Clinical Impact of Intravascular Ultrasound-Based Artificial Intelligence Technologies (INNOVATE-PCI)
NCT0580784116 locations
Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease
NCT0583108539 locations
PREVAIL Paclitaxel-coated Balloon in Small Coronary Disease and High-bleeding Risk Patients
NCT0632175719 locations